Prosetta, antiviral drug, raises $2M

May 21, 2007 | Matt Marshall | Comments | |

See David Hamilton’s story.

Next Story: Vivaldi scoops up $2M for flu vaccines
Previous Story: Roundup: Peak coal, Yahoo-Bebo rumors, Mixercast and much more

Bookmark and Share

Photo of Matt Marshall

About the Author, Matt Marshall

Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.